title: Abnormal aldosterone physiology and cardiometabolic risk factors.
abstract: Abnormal aldosterone physiology has been implicated in the pathogenesis of cardiometabolic diseases. Single aldosterone measurements capture only a limited range of aldosterone physiology. New methods of characterizing aldosterone physiology may provide a more comprehensive understanding of its relationship with cardiometabolic disease. We evaluated whether novel indices of aldosterone responses to dietary sodium modulation, the sodium-modulated aldosterone suppression-stimulation index (SASSI for serum and SAUSSI for urine), could predict cardiometabolic risk factors. We performed cross-sectional analyses on 539 subjects studied on liberal and restricted sodium diets with serum and urinary aldosterone measurements. SASSI and SAUSSI were calculated as the ratio of aldosterone on liberal (maximally suppressed aldosterone) to the aldosterone on restricted (stimulated aldosterone) diets and associated with risk factors using adjusted regression models. Cardiometabolic risk factors associated with either impaired suppression of aldosterone on liberal diet, or impaired stimulation on restricted diet, or both; in all of these individual cases, these risk factors associated with higher SASSI or SAUSSI. In the context of abnormalities that constitute the metabolic syndrome, there was a strong positive association between the number of metabolic syndrome components (0-4) and both SASSI and SAUSSI (P<0.0001) that was independent of known aldosterone secretagogues (angiotensin II, corticotropin, potassium). SASSI and SAUSSI exhibited a high sensitivity in detecting normal individuals with zero metabolic syndrome components (86% for SASSI and 83% for SAUSSI). Assessing the physiological range of aldosterone responses may provide greater insights into adrenal pathophysiology. Dysregulated aldosterone physiology may contribute to, or result from, early cardiometabolic abnormalities.
authors: Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women's Hospital, Boston, MA 02115, USA. avaidya1@partners.org
authors: Anand
authors: A
authors: Vaidya
authors: Patricia C
authors: PC
authors: Underwood
authors: Paul N
authors: PN
authors: Hopkins
authors: Xavier
authors: X
authors: Jeunemaitre
authors: Claudio
authors: C
authors: Ferri
authors: Gordon H
authors: GH
authors: Williams
authors: Gail K
authors: GK
authors: Adler
mesh_terms: D000450:Aldosterone / Q000502:physiology*; D003430:Cross-Sectional Studies; D005260:Female; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000453:epidemiology / Q000503:physiopathology*; D015994:Incidence; D008297:Male; D024821:Metabolic Syndrome / Q000097:blood / Q000453:epidemiology / Q000503:physiopathology; D008875:Middle Aged; D012083:Renin / Q000097:blood; D012307:Risk Factors; D014481:United States / Q000453:epidemiology
chemical_list: D000450:Aldosterone; D012083:Renin
references: J Clin Endocrinol Metab. 2012 Jul;97(7):2456-65
references: 22539586
references: J Clin Invest. 1972 Aug;51(8):1950-7
references: 5054456
references: Hypertension. 2012 May;59(5):1069-78
references: 22493070
references: Diabetes Care. 1996 May;19(5):414-8
references: 8732701
references: J Clin Endocrinol Metab. 1983 Oct;57(4):764-70
references: 6309884
references: Ann Epidemiol. 2000 Jul;10(5):263-70
references: 10942873
references: Prostaglandins Leukot Essent Fatty Acids. 1999 May-Jun;60(5-6):401-5
references: 10471129
references: J Clin Endocrinol Metab. 2010 Apr;95(4):1986-90
references: 20130077
references: Am J Kidney Dis. 2011 Mar;57(3):403-14
references: 21186074
references: BMC Geriatr. 2010 Nov 11;10:85
references: 21070664
references: Hypertension. 2012 Apr;59(4):893-8
references: 22353614
references: Diabetologia. 1985 Jul;28(7):412-9
references: 3899825
references: Obes Res. 1999 Jul;7(4):355-62
references: 10440591
references: J Clin Endocrinol Metab. 2008 Jul;93(7):2566-71
references: 18445663
references: J Clin Endocrinol Metab. 2012 Oct;97(10):3775-82
references: 22865897
references: Am J Hypertens. 1995 Sep;8(9):870-5
references: 8541001
references: Curr Hypertens Rep. 2010 Aug;12(4):252-7
references: 20563672
references: Hypertension. 1995 Jan;25(1):30-6
references: 7843750
references: Prog Cardiovasc Dis. 2010 Mar-Apr;52(5):401-9
references: 20226958
references: Hypertension. 2009 Apr;53(4):605-10
references: 19221213
references: Biol Res Nurs. 2007 Apr;8(4):305-18
references: 17456592
references: Diabetes Res Clin Pract. 2007 Nov;78(2):225-33
references: 17467842
references: Metabolism. 2010 Apr;59(4):457-62
references: 19846173
references: J Clin Endocrinol Metab. 2007 Nov;92(11):4472-5
references: 17726083
references: Circulation. 2007 Aug 28;116(9):984-92
references: 17698726
references: J Clin Invest. 1983 Dec;72(6):2115-24
references: 6358261
references: Diabetes Care. 2003 Mar;26(3):575-81
references: 12610004
references: Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14211-6
references: 14614137
references: Hypertension. 2006 Aug;48(2):239-45
references: 16785327
references: Diabet Med. 1998 Jul;15(7):539-53
references: 9686693
references: Hypertension. 2008 May;51(5):1252-8
references: 18347227
references: Am J Hypertens. 1999 Apr;12(4 Pt 1):348-55
references: 10232494
references: J Hypertens. 2001 Jan;19(1):99-105
references: 11204310
references: Diabetes. 1999 Aug;48(8):1623-30
references: 10426382
references: Curr Hypertens Rep. 2011 Apr;13(2):163-72
references: 21279740
references: Eur J Endocrinol. 2011 Jun;164(6):995-1002
references: 21402748
references: Atherosclerosis. 2011 Dec;219(2):875-9
references: 21968318
references: J Clin Endocrinol Metab. 2011 Aug;96(8):E1288-92
references: 21613355
references: J Clin Invest. 1972 Jul;51(7):1731-42
references: 4338121